Prague Med. Rep. 2025, 126, 63-74

https://doi.org/10.14712/23362936.2025.11

Modern Trends in Cancer Diagnosis and Treatment: Innovative Aspects

Altin Goxharaj1ID, Kushtrim Salihu2ID, Chinara Zhylkichieva3ID, Aigul Matkeeva4ID, Maral Turdumatova5ID

1Department of Nursing, “Eqrem Çabej” University of Gjirokastra, Gjirokastra, Albania
2Department of Nursing, AAB College, Pristina, Republic of Kosovo
3Department of Paediatrics, Obstetrics and Gynaecology, International University of the Kyrgyz Republic, Bishkek, Kyrgyz Republic
4Department of Neurology, National Center of Maternity and Childhood Care, Bishkek, Kyrgyz Republic
5First Children’s Hospice, Bishkek, Kyrgyz Republic

Received January 21, 2025
Accepted May 12, 2025

References

1. Alkhathami, A. G., Hadi, A., Alfaifi, M., Alshahrani, M. Y., Verma, A. K., Beg, M. M. A. (2022) Serum-based lncRNA ANRIL, TUG1, UCA1, and HIT expressions in breast cancer patients. Dis. Markers 2022, 9997212. <https://doi.org/10.1155/2022/9997212>
2. Alromi, D. A., Madani, S. Y., Seifalian, A. (2021) Emerging application of magnetic nanoparticles for diagnosis and treatment of cancer. Polymers 13(23), 4146. <https://doi.org/10.3390/polym13234146>
3. Ambrosio, L., Raucci, M. G., Vadalà, G., Ambrosio, L., Papalia, R., Denaro, V. (2021) Innovative biomaterials for the treatment of bone cancer. Int. J. Mol. Sci. 22(15), 8214. <https://doi.org/10.3390/ijms22158214>
4. Assumpção, P., Araújo, T., Khayat, A., Ishak, G., Santos, S., Barra, W., Acioli, J. F., Rossi, B., Assumpção, P. (2020) Hereditary gastric cancer: Three rules to reduce missed diagnoses. World J. Gastroenterol. 26(13), 1382–1393. <https://doi.org/10.3748/wjg.v26.i13.1382>
5. Bai, J. W., Qiu, S. Q., Zhang, G. J. (2023) Molecular and functional imaging in cancer-targeted therapy: Current applications and future directions. Signal Transduct. Target. Ther. 8, 89. <https://doi.org/10.1038/s41392-023-01366-y>
6. Begolli, G., Marković, I., Knežević, J., Debeljak, Ž. (2023) Carbohydrate sulfotransferases: A review of emerging diagnostic and prognostic applications. Biochem. Med. (Zagreb) 33(3), 030503.
7. Betti, M., Vizza, E., Piccione, E., Pietropolli, A., Chiofalo, B., Pallocca, M., Bruno, V. (2023) Towards reproducible research in recurrent pregnancy loss immunology: Learning from cancer microenvironment deconvolution. Front. Immunol. 14, 1082087. <https://doi.org/10.3389/fimmu.2023.1082087>
8. Bhinder, B., Gilvary, C., Madhukar, N. S., Elemento, O. (2021) Artificial intelligence in cancer research and precision medicine. Cancer Discov. 11(4), 900–915. <https://doi.org/10.1158/2159-8290.CD-21-0090>
9. Bilyalov, A., Nikolaev, S., Danishevich, A., Khatkov, I., Makhmudov, K., Isakova, Z., Bakirov, N., Omurbaev, E., Osipova, A., Ramaldanov, R., Shagimardanova, E., Kiyasov, A., Gusev, O., Bodunova, N. (2023) The spectrum of germline nucleotide variants in gastric cancer patients in the Kyrgyz Republic. Curr. Issues Mol. Biol. 45(8), 6383–6394. <https://doi.org/10.3390/cimb45080403>
10. Bruno, V., Logoteta, A., Chiofalo, B., Mancini, E., Betti, M., Fabrizi, L., Piccione, E., Vizza, E. (2024) It is time to implement molecular classification in endometrial cancer. Arch. Gynecol. Obstet. 309, 745–753. <https://doi.org/10.1007/s00404-023-07128-z>
11. Chamberlin, M. D., Islami, D. A., Barth, R. J. Jr., Demaci, S. (2024) Breast cancer disparities and innovations: A focus on Kosovo. Hematol. Oncol. Clin. North Am. 38(1), 199–207. <https://doi.org/10.1016/j.hoc.2023.06.002>
12. Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Jayasankar, N., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., Saadh, M. J., Amajd, A., Abo-Zaid, M. A., Castillo-Acobo, R. Y., Ismail, A. H., Amin, A. H., Akhavan-Sigari, R. (2023) Progressing nanotechnology to improve targeted cancer treatment: Overcoming hurdles in its clinical implementation. Mol. Cancer 22(1), 169. <https://doi.org/10.1186/s12943-023-01865-0>
13. Chen, Z. H., Lin, L., Wu, C. F., Li, C. F., Xu, R. H., Sun, Y. (2021) Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine. Cancer Commun. (Lond.) 41(11), 1100–1115. <https://doi.org/10.1002/cac2.12215>
14. Craig, A. W., Frieboes, H. B., Videira, P. A. (2024) Advancing cancer immunotherapy: From innovative preclinical models to clinical insights. Sci. Rep. 14, 1205. <https://doi.org/10.1038/s41598-024-51704-5>
15. Dell’Acqua, V., Surgo, A., Arculeo, S., Zerella, M. A., Bagnardi, V., Frassoni, S., Zampino, M. G., Ravenda, P. S., Rotundo, M. S., Kraja, F., Kobiela, J., Spychalski, P., Fodor, C., Gerardi, M. A., Cattani, F., Bazani, A., Petz, W., Glynne-Jones, R., Orecchia, R., Leonardi, M. C., Jereczek-Fossa, B. A. (2020) Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: Acute and early-late toxicity, outcome, and efficacy. Int. J. Colorectal Dis. 35, 685–694. <https://doi.org/10.1007/s00384-020-03517-x>
16. Egwu, C. O., Aloke, C., Onwe, K. T., Umoke, C. I., Nwafor, J., Eyo, R. A., Chukwu, J. A., Ufebe, G. O., Ladokun, J., Audu, D. T., Agwu, A. O., Obasi, D. C., Okoro, C. O. (2024) Nanomaterials in drug delivery: Strengths and opportunities in medicine. Molecules 29(11), 2584. <https://doi.org/10.3390/molecules29112584>
17. Fejza, A., Carobolante, G., Poletto, E., Camicia, L., Schinello, G., Di Siena, E., Ricci, G., Mongiat, M., Andreuzzi, E. (2023) The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: A systematic review of the literature. Front. Immunol. 14, 1270981. <https://doi.org/10.3389/fimmu.2023.1270981>
18. Fisher, L., Fisher, O., Chebanov, D., Vesnin, S., Goltsov, A., Turnbull, A., Dixon, M., Kudaibergenova, I., Osmonov, B., Karbainov, S., Popov, L., Losev, A., Goryanin, I. (2023) Passive microwave radiometry and microRNA detection for breast cancer diagnostics. Diagnostics (Basel) 13(1), 118. <https://doi.org/10.3390/diagnostics13010118>
19. Gao, J., Xu, B., Lin, Y., Xu, Z., Huang, M., Li, X., Wu, X., Chen, Y. (2022) Stereotactic body radiotherapy boost with the CyberKnife for locally advanced cervical cancer: Dosimetric analysis and potential clinical benefits. Cancers 14(20), 5166. <https://doi.org/10.3390/cancers14205166>
20. Graiqevci-Uka, V., Behluli, E., Spahiu, L., Liehr, T., Temaj, G. (2023) Targeted treatment and immunotherapy in high-risk and relapsed/refractory pediatric acute lymphoblastic leukemia. Curr. Pediatr. Rev. 19(2), 150–156.
21. Gupta, V., Gupta, R., Aggrawal, R., Chhatre, A. (2024) Clinicopathological response and breast conservation in locally advanced breast cancer cases treated with neoadjuvant chemotherapy. Int. J. Med. Med. Res. 10(2), 16–25. <https://doi.org/10.61751/ijmmr/2.2024.16>
22. Hussain, M. S., Moglad, E., Afzal, M., Bansal, P., Kaur, H., Deorari, M., Ali, H., Shahwan, M., Hassan Almalki, W., Kazmi, I., Alzarea, S. I., Singh, S. K., Dua, K., Gupta, G. (2024) Circular RNAs in the KRAS pathway: Emerging players in cancer progression. Pathol. Res. Pract. 256, 155259. <https://doi.org/10.1016/j.prp.2024.155259>
23. Khan, N. A., Asim, M., Biswas, K. H., Alansari, A. N., Saman, H., Sarwar, M. Z., Osmonaliev, K., Uddin, S. (2023) Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: Recent advances and emerging concepts. J. Exp. Clin. Cancer Res. 42, 221. <https://doi.org/10.1186/s13046-023-02753-7>
24. Kwak, M. H., Yang, S. M., Yun, S. K., Kim, S., Choi, M. G., Park, J. M. (2021) Identification and validation of LGR5-binding peptide for molecular imaging of gastric cancer. Biochem. Biophys. Res. Commun. 580, 93–99. <https://doi.org/10.1016/j.bbrc.2021.09.073>
25. Liu, Z., Lu, T., Qian, R., Wang, Z., Qi, R., Zhang, Z. (2024) Exploiting nanotechnology for drug delivery: Advancing the anti-cancer effects of autophagy-modulating compounds in traditional Chinese medicine. Int. J. Nanomedicine 19, 2507–2528. <https://doi.org/10.2147/IJN.S455407>
26. Luo, X. J., Zhao, Q., Liu, J., Zheng, J. B., Qiu, M. Z., Ju, H. Q., Xu, R. H. (2021) Novel genetic and epigenetic biomarkers of prognostic and predictive significance in stage II/III colorectal cancer. Mol. Ther. 29(2), 587–596. <https://doi.org/10.1016/j.ymthe.2020.12.017>
27. Minervini, G., Meto, A., Fiorillo, L., Franco, R., di Francesco, F., Cicciù, M., Cervino, G. (2023) Salivary microRNAs as innovative biomarkers for early diagnosis of oral diseases: A comparison of conventional cigarette smokers and tobacco heating system 2.2 users. Minerva Dent. Oral Sci. 72(5), 247–254. <https://doi.org/10.23736/S2724-6329.23.04790-3>
28. Nenoff, L., Matter, M., Hedlund Lindmar, J., Weber, D. C., Lomax, A. J., Albertini, F. (2019) Daily adaptive proton therapy – The key to innovative planning approaches for paranasal cancer treatments. Acta Oncol. 58(10), 1423–1428. <https://doi.org/10.1080/0284186X.2019.1641217>
29. Posolenyk, L. (2024) Functional-structural reorganisation of salivary glands in oncological pathology: A mini-review. Bull. Med. Biol. Res. 6(3), 60–65. <https://doi.org/10.61751/bmbr/3.2024.60>
30. Sadeghnejad Barkousaraie, A., Ogunmolu, O., Jiang, S., Nguyen, D. (2020) A fast deep learning approach for beam orientation optimization for prostate cancer treated with intensity-modulated radiation therapy. Med. Phys. 47(3), 880–897. <https://doi.org/10.1002/mp.13986>
31. Shala, A. L., Arduino, I., Salihu, M. B., Denora, N. (2023) Quercetin and its nano-formulations for brain tumor therapy – Current developments and future perspectives for paediatric studies. Pharmaceutics 15(3), 963. <https://doi.org/10.3390/pharmaceutics15030963>
32. Soyka, L., Kovalchuk, O., Upatova, I. (2024) Hormonal and other methods of thyroid gland examination: A literature review. Bull. Med. Biol. Res. 6(2), 85–92. <https://doi.org/10.61751/bmbr/2.2024.85>
33. Temaj, G., Chichiarelli, S., Telkoparan-Akillilar, P., Saha, S., Nuhii, N., Hadziselimovic, R., Saso, L. (2024) Advances in molecular function of UPF1 in cancer. Arch. Biochem. Biophys. 756, 109989. <https://doi.org/10.1016/j.abb.2024.109989>
34. World Health Organization (2024) Global cancer burden growing, amidst mounting need for services. Available at: https://www.who .int/ru/news/item/01-02-2024-global-cancer-burden-growing-amidst-mounting-need-for-services
35. Yap, T. A., Parkes, E. E., Peng, W., Moyers, J. T., Curran, M. A., Tawbi, H. A. (2021) Development of immunotherapy combination strategies in cancer. Cancer Discov. 11(6), 1368–1397. <https://doi.org/10.1158/2159-8290.CD-20-1209>
36. Zaki, P., Chuong, M. D., Schaub, S. K., Lo, S. S., Ibrahim, M., Apisarnthanarax, S. (2023) Proton beam therapy and photon-based magnetic resonance image-guided radiation therapy: The next frontiers of radiation therapy for hepatocellular carcinoma. Technol. Cancer Res. Treat. 22, 15330338231206335. <https://doi.org/10.1177/15330338231206335>
37. Zheng, J., Huang, R., Lin, Z., Chen, S., Yuan, K. (2024) Nano/micromotors for cancer diagnosis and therapy: Innovative designs to improve biocompatibility. Pharmaceutics 16(1), 44. <https://doi.org/10.3390/pharmaceutics16010044>
38. Zub, V., Kotuza, A., Tolstanov, O. (2022) Communication of oncological patients with oncologists: Main problems and problem-solving strategies. Int. J. Med. Med. Res. 8(2), 74–82. <https://doi.org/10.11603/ijmmr.2413-6077.2022.2.13594>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive